These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3138540)

  • 1. Elevated levels of soluble interleukin-2 receptors in multiple sclerosis.
    Greenberg SJ; Marcon L; Hurwitz BJ; Waldmann TA; Nelson DL
    N Engl J Med; 1988 Oct; 319(15):1019-20. PubMed ID: 3138540
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the expression of the interleukin 2 receptor on the lymphocytes of patients with multiple sclerosis using anti-Tac monoclonal antibodies].
    Selmaj K; Plater-Zyberk C; Rockett KA; Alam R; Maini RN; Perkin GD; Rose FC
    Pol Tyg Lek; 1987 Nov; 42(44):1389-91. PubMed ID: 3128776
    [No Abstract]   [Full Text] [Related]  

  • 3. [The level of soluble forms of interleukin-2 receptor and adhesive molecules ICAM-1 and VCAM-1 in platelets of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Pol Merkur Lekarski; 1999 Jan; 6(31):23-6. PubMed ID: 10344149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitopic analysis of the human interleukin 2 receptors by the use of monoclonal antibodies: epitope-function relationship.
    Le Mauff B; Olive D; Moreau JF; Soulillou JP; Jacques Y
    Transplant Proc; 1987 Feb; 19(1 Pt 1):281-4. PubMed ID: 2435029
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis.
    Merrill JE; Mohlstrom C; Uittenbogaart C; Kermaniarab V; Ellison GW; Myers LW
    J Immunol; 1984 Oct; 133(4):1931-7. PubMed ID: 6088630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
    Taniguchi N; Miyawaki T; Yachie A
    Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal anti-IL-2 receptor antibody in primate renal transplantation.
    Shapiro ME; Kirkman RL; Reed MH; Puskas JD; Mazoujian G; Letvin NL; Carpenter CB; Milford EL; Waldmann TA; Strom TB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):594-8. PubMed ID: 3103282
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.
    Hofman FM; von Hanwehr RI; Dinarello CA; Mizel SB; Hinton D; Merrill JE
    J Immunol; 1986 May; 136(9):3239-45. PubMed ID: 3082983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin 2 receptors are released by long term-cultured insulin-specific T cells transiently after contact with antigen.
    Reske-Kunz AB; Osawa H; Josimović-Alasević O; Rüde E; Diamantstein T
    J Immunol; 1987 Jan; 138(1):192-6. PubMed ID: 3097145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum levels of soluble interleukin-2 receptors in sarcoidosis.
    Semenzato G; Cipriani A; Trentin L; Zambello R; Masciarelli M; Vinante F; Chilosi M; Pizzolo G
    Sarcoidosis; 1987 Mar; 4(1):25-7. PubMed ID: 3108983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of IL-2 in normal and disturbed immune functions in the chicken.
    Schauenstein K; Krömer G; Fässler R; Wick G
    Prog Clin Biol Res; 1987; 233():69-77. PubMed ID: 3108902
    [No Abstract]   [Full Text] [Related]  

  • 12. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.
    Bellamy AS; Calder VL; Feldmann M; Davison AN
    Clin Exp Immunol; 1985 Aug; 61(2):248-56. PubMed ID: 3930109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.
    Braakman E; van Tunen A; Meager A; Lucas CJ
    Clin Exp Immunol; 1986 Nov; 66(2):285-94. PubMed ID: 2949897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytes.
    Selmaj K; Plater-Zyberk C; Rockett KA; Maini RN; Alam R; Perkin GD; Rose FC
    Neurology; 1986 Oct; 36(10):1392-5. PubMed ID: 2429234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
    Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
    J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis.
    Adachi K; Kumamoto T; Araki S
    Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of interleukin 2 receptor and class II histocompatibility antigens on lymphocytes of the cerebrospinal fluid in patients with multiple sclerosis and other neurological diseases].
    Tournier-Lasserve E; Lyon-Caen O; Roullet E; Bach MA
    Pathol Biol (Paris); 1987 Mar; 35(3):303-6. PubMed ID: 3108835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble interleukin-2 receptor in haematological disorders.
    Pizzolo G; Chilosi M; Semenzato G
    Br J Haematol; 1987 Dec; 67(4):377-80. PubMed ID: 3122815
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin 2 receptor: two distinct proteins bind interleukin 2.
    Ruscetti FW
    Year Immunol; 1988; 3():129-37. PubMed ID: 2831679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.